Cerevance
Latest round
- Series C
Last raised
- May 2026
Total raised
- $205M
Investors
- 15
About Cerevance
Established in 2016 and based in Massachusetts, US, Cerevance, LLC researches and develops therapeutics for the treatment of neurological and psychiatric disorders. The company was co-founded by Brad Margus. The company specializes in developing therapies for central nervous system (CNS) disorders using its proprietary NETSseq platform. This advanced technology utilizes human data and machine learning to identify targets in single cell types or those altered by disease, allowing for precision in treatment development. Cerevance's approach provides therapeutic options with minimal off-target effects, addressing some of the CNS conditions. The company’s pipeline, including the ASCEND study for Parkinson's disease, is at the forefront of precision neuroscience and CNS disorder treatment.
Who invested in Cerevance
15 investors across 6 rounds
See all investors in Cerevance
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cerevance
Who invested in Cerevance?
Cerevance has 15 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cerevance raised?
Cerevance has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Cerevance last raise money?
Cerevance's most recent round on record is a Series C, in May 2026.
What does Cerevance do?
Established in 2016 and based in Massachusetts, US, Cerevance, LLC researches and develops therapeutics for the treatment of neurological and psychiatric disorders.
Where is Cerevance headquartered?
Cerevance is headquartered in Boston, US.
Which VCs invest in companies like Cerevance?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cerevance's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Cerevance? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.